Global Neurocosmetics Market 2025 – 2034
<p><strong>Reports Description</strong> <p>As per the <strong>Neurocosmetics Market</strong> analysis conducted by the CMI Team, the global Neurocosmetics Market is expected to record a <strong>CAGR of 8.5%</strong> from 2025 to 2034. In 2025, the market size is projected to reach a valuation of <strong>USD 2.1 Billion</strong>. By 2034, the valuation is anticipated to reach <strong>USD 3.5 Billion</strong>.</p></p> <h3>Overview</h3> <p>Recent innovations in the global neurocosmetics marketplace emphasize sustainable manufacturing practices and construction of intelligent systems for bulk cash deliveries and for secure, AI-enhanced management of supply chains. Businesses increasingly seek sustainable manufacturing and energy-conserving designs that include ecologically responsible production and energy-efficient designs.</p> <p>Implementing smart packaging that uses RFID and NFC technology mitigates deliberate tampering and improves transparency and protection. AI for demand forecasting and process optimization streamlines supply chain logistics and cold chain management and improves operational efficiencies. These innovations improve safety and reliability and strengthen consumer focus, likely leading to enhanced global market competitiveness.</p> <h3>Key Trends & Drivers</h3> <ul> <li><strong>Retail Outlets and Further Global Distribution: </strong>Neraeu's first retail boutique opened in Paris in July 2024 and, for the first time, the company began its international expansion with the opening of its boutique at Wells Stores in Portugal in October 2025. These new openings strengthened the company's position in the market and provided consumers with their first opportunity to experience, in person, the neurocosmetics. Expanded retail improved consumer engagement, trust, and loyalty, allowing them to test the company's neuro-textures and fragrances and understand the science of the products, and the international expansion improved retail impact in the marketplace and Neurae's credibility in the marketplace. Neurae's skincare products based on neuroscience are marketable. These factors greatly increased the sales growth and Neurae's market penetration.</li> </ul> <ul> <li><strong>Developing New Neuro Active Products: </strong>In September 2024, Justhuman/Swanrose Inc. moved to the forefront of the market when the company introduced the first of its kind Microshots Age-Defying Peptide Treatment Cream. Unlike other products on the market, Justhuman's Microshots Age-Defying Peptide Treatment Cream contains neurocosmetics and neuropeptides, which the company claimed enhance collagen production and repair stressed skin. The company's micro-delivery system, which Justhuman patented, ensures deep skin penetration and optimal results. Each consumer benefits from measurable results, with anti-aging effects and general wellness improvement, unlike products on the market. The products deliver visible skin benefits and also cognitive-sensory improvements. Other competitors have tried without success to deliver differentiated formulations with the claims Justhuman has, and the company reflects the increased consumer demand of integrated science with personal emotion.</li> </ul> <h3>Major Risks</h3> <ul> <li><strong>Global Supply and Manufacturing Gaps: </strong>As of April 2025, Sisley experienced supply shortages affecting the Neuraé line because the company could not scale production adequately in its French and European facilities. These supply chain gaps resulted in order fulfilment delays, exposing supply chain weaknesses in the global neurocosmetics market. Should demand grow without the ability to manufacture additional inventory, potential revenue loss and brand loyalty may evaporate due to consumer frustration. Strengthening operational deficiencies is imperative, as collocated production, enhanced distribution networks, and warehousing all will require the allocation of additional staff to mitigate the risk. Continued market operability will be at risk should these supply and demand gaps persist.</li> </ul> <ul> <li><strong>New entrants and Attempts at Differentiation Across the Segment: </strong>March 2025 saw Algenist enter the market to compete with the newly released Neuro‑Peptide Serum, designed to address the dermatological effects of stress. As neurocosmetics is one of the most fragmented markets, the entry of numerous competitors such as LUKSO, Justhuman, and most recently Algenist, each with formulations for neuro-active peptide skincare, elevates market dysregulation. Sustained market placement is dependent on advanced research and the allocation of resources to address marketing, promotion, and consumer education. Less financially sustainable players may collapse under this level of market innovation in the form of patented technologies.</li> </ul> <h3>Opportunities</h3> <ul> <li><strong>Increased Accessibility and Market Diversification: </strong>As of April 2025, Arkana Cosmetics is increasing its Latin America and Southeast Asia Market. They will now offer regionally defined pricing and accessibility programs, allowing for greater brand penetration and establishing a presence in the neurocosmetics markets. Expanded presence in emerging markets offers greater long-term revenues and greater adoption of neurocosmetic solutions. These markets will also benefit from relaxed regulations and a focus on customized products, allowing for a stronger market expansion.</li> </ul> <ul> <li><strong>Advancements in Novel, Easy-to-Use and Sustained Release Technologies: </strong>In February 2025, Amyris, Inc. is expected to launch a new line of neurocosmetic serums and sustained release neuropeptide creams aimed at less frequent applications while offering improvements in skin repair and cognitive benefits. These formulations mitigate the user burden, improve adherence, and appeal to neurocosmetic consumers. Drove product retention innovation and increased competitiveness while attracting consumers seeking lower frequency usage neurocosmetics. Technologies aimed at improving formulation represent one of the greatest opportunities for sustaining neurocosmetic market growth.</li> </ul> <h3>Category Wise Insights</h3> <p><strong>By Type of Product </strong></p> <ul> <li><strong>Body Care: </strong>Neurocosmetic body care products, like creams, lotions and serums, including those that address skin-related concerns and emotional well-being. L’Oréal Revitalift, which also uses neuroactive peptides paired with antioxidants to enhance skin relaxation and firmness, launched in March 2023. These products provide a sensory neuro-stimulative experience, improving skin tone, texture and resilience while also improving functional mind overload and relaxation stimulation - sarcao, and whereby the products improve elastic skin.</li> </ul> <ul> <li><strong>Face Care: </strong>Of all the segments, face care neurocosmetics remained the largest, whereby from wrinkles, fine lines, and stressed emotional skin, face care products help, and in April 2023, Estée Lauder extended her Advanced Night Repair line to incorporate Neuro-Serum with neuroactive peptides and calming bioactives. The neurocosmetic serums for the face combined visible anti-aging with the neuroactive benefits, making them even more preferred for boutique and elite mass-market segments, with neuro-serums fueling high competition with visible lines and areas of disappearance.</li> </ul> <ul> <li><strong>Hair Care: </strong>Neurocosmetic hair products are focused on scalp health, stress-induced hair thinning, and follicle nourishment. In February 2023 to uplift the commerce's distressed emotional state through peptide adaptogens; Amyris, Inc. Neuro-Hair Revitalizing Shampoo was introduced to reduce emotional-stress triggered hair loss. These dual products align with the increasing awareness of the scalp - brain connection to stress and provide hair care and well-being.</li> </ul> <ul> <li><strong>Color Cosmetics: </strong>May 2025 brought us Sisley's Neuraé Mood Lipstick Line, a collection of cosmetics that targets depression and dullness of the lips with neuro-active ingredients. The launch of this item created a market for other color cosmetics with similar dual attributes: aesthetics and neurocosmetic benefits, which allow for the automation of active constituents geared toward a cognitive and emotional response with the use of the makeup.</li> </ul> <ul> <li><strong>Bath Products: </strong>Neurocosmetic gels, oils, and salts, including bath products, are designed to help with mood and hydration while enhancing relaxation. GINGER & ME (INSKIN COSMEDICS) brought to market Neuro-Bath Ritual Oils in March 2025, which incorporates neurosensory fragrances, along with skin calming botanicals, to promote complete immersion for stress relief and relaxation for the user. The use of neurocosmetics is no longer limited to skincare.</li> </ul> <ul> <li><strong>Other: </strong>Neurocosmetics with an emotional target and skin-brain homeostasis include patches, masks, and supplements. LUKSO Neuro-Skin Patches, with extended-release peptides for chronic stress skin sequelae, were released in April 2025. This category encourages brands to incorporate specialized multi-sensory techniques for customer interaction and, along with innovative delivery systems, adds to the appeal of the products.</li> </ul> <p><strong>By Consumer Group</strong></p> <ul> <li><strong>Men: </strong>The sector is growing for men, factoring in stress-related skin issues, anti-aging, and general wellness. In February 2025, Algenist launched Neuro-Active Men's Serum, aimed at targeting the visible effects of stress and fatigue on men's skin. There is an increasing male wellness market; brands are developing calming male formulations with neuropeptides.</li> </ul> <ul> <li><strong>Women: </strong>The largest market for neurocosmetics is women. Women seek functional skin care for stress, aging, and emotional fatigue. In April 2025, Sisley's Neuraé Facial Serum launched an emotional and hormonal skin stress line within the new formulations, targeting the growing market of neurocosmetics for women.</li> </ul> <p><strong>By Distribution Channel </strong></p> <ul> <li><strong>Online: </strong>For convenience, home delivery, and access to neurocosmetics from all over the world, online pharmacies and e-commerce are essential. In March 2025, SkinSoul Cosmetics, for home delivery and subscriptions, offered an online-exclusive Neuro-Skin Wellness Kit with guidance on how to use the products. Brand loyalty and adherence to products are on the rise because of educational content and automated reminders on online platforms.<strong> </strong></li> </ul> <ul> <li><strong>Offline: </strong>For personalized consultations and sensory experiences, retail boutiques, department stores, and spas are all online. In July 2024, Sisley opened its flagship Neuraé Boutique in Paris, offering multisensory experiences with neurocosmetics and educational interactions. Strong credible brands with physical stores are able to market competitively at an experiential level, attracting premium customers.</li> </ul> <h3>Historical Context</h3> <p>Innovators in the Neurocosmetics Market continue to transform the forefront of Personal Care. Integrative biotech, clinical studies, AI, and sustainability in cosmetics create a paradigm of safe personalization. Their innovation advances the consumer's ability to personalize their wellness while positively impacting world health and sustainability.</p> <h3>Impact of Recent Trade and Tariff Regulations</h3> <p>The Global Neurocosmetics Market is being impacted from Trade Policy and Tariff Regulation on North America, Europe and Asia/Pacific. The evaluation of import tariffs from active ingredients, raw materials, packaging, and specialized delivery systems. Produced costs are rising on the neurocosmetic formulation and companies are reframing their prices, costs of production, and compliance to supply varying regional costs of product safety, labeling, and sustainability.</p> <p>To address the impact, the leading Neurocosmetic manufacturers have moved their production, R&D, and procurement to cost friendly emerging markets such as India, Malaysia, Vietnam, and Mexico. These countries have an established supply chain integration, low production costs, and advantageous trade relations with developed countries. Besides, there are trained personnel, and rising industries of cosmetics and pharma in these areas offer the companies the required means to stay in the global market and assure constant availability of products.</p> <p>In the face of intricate cross-border trading challenges, businesses are more often incorporating systems of digital compliance, digital trade management, automated customs processing, and blockchain supply chain monitoring. These improvements enhance trade efficiency, streamline operational risks, and increase trade resilience. The Neurocosmetics Market, dissociating its supply chain and incorporating sustainable practices, is adapting to mitigate the impact of price increases, regulatory challenges, and tariffs, whilst ensuring consumers maintain steady access to quality products.</p> <p><strong>Report Scope</strong></p> <table> <tbody> <tr> <td><strong>Feature of the Report</strong></td> <td><strong>Details</strong></td> </tr> <tr> <td>Market Size in 2025</td> <td>USD 2.1 Billion</td> </tr> <tr> <td>Projected Market Size in 2034</td> <td>USD 3.5 Billion</td> </tr> <tr> <td>Market Size in 2024</td> <td>USD 1.95 Billion</td> </tr> <tr> <td>CAGR Growth Rate</td> <td>8.5% CAGR</td> </tr> <tr> <td>Base Year</td> <td>2024</td> </tr> <tr> <td>Forecast Period</td> <td>2025-2034</td> </tr> <tr> <td>Key Segment</td> <td>By Product Type, Consumer Group, Distribution Channel and Region</td> </tr> <tr> <td>Report Coverage</td> <td>Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends</td> </tr> <tr> <td>Regional Scope</td> <td>North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America</td> </tr> <tr> <td>Buying Options</td> <td>Request tailored purchasing options to fulfil your requirements for research.</td> </tr> </tbody> </table> <h3>Regional Perspective</h3> <p><strong>North America: </strong>North America has remained the leader in the <a href="https://custommarketinsights.com/press-releases/neurocosmetics-market-size/">Neurocosmetic market</a>, owing to the good healthcare facilities, strong awareness of consumers on functional skincare, and rapid uptake of neurocosmetic treatments. Clinics and hospitals also have integrated digital health tools, patient monitoring, and prescription adherence programs, which are beneficial to the region.</p> <ul> <li><strong>United States: </strong>In March 2025, L’Oréal has extended its distribution of neuro-active facial and body care in the U.S. both in retail outlets and online. Consumer education programs and clinic alliances were facilitating its growth, focusing on skin-related stress issues, emotional aging, and wellness. The adoption is further enhanced by FDA approvals and patient-access programs in several states.</li> </ul> <ul> <li><strong>Canada: </strong>In June 2024, Estée also partnered with Canadian clinics to offer organized instructional interventions to patients using neurocosmetic serums and creams. Such initiatives increased understanding of neuro-active skincare advantages, the correct usage, and its increased use in urban and semi-urban populations.</li> </ul> <ul> <li><strong>Mexico: </strong>In April 2025, Sisley collaborated with local pharmacies in urban and peri-urban areas to make sure that its Neurae line is distributed readily. Demand is being fueled by increased awareness of chronic diseases and the emergence of interest in functional wellness and emotional skin care. These collaborations enhance the accessibility of consumers with the help of preserving the premium positioning of products.</li> </ul> <p><strong>Europe: </strong>Europe is a powerful market because it has good systems of public health, high levels of regulatory standards and a focus on sustainability, patient safety and functional adoption of skincare<strong>.</strong></p> <ul> <li><strong>Germany: </strong>In May 2025, Sanofi enhanced collaboration with the networks of hospitals and incorporated the neurocosmetic education program as a part of primary care. This allowed the healthcare professionals to provide guidance to patients regarding emotional wellness, cognitive skin benefits and adherence that enhanced the patient outcomes and therapy acceptance.</li> </ul> <ul> <li><strong>United Kingdom: </strong>AstraZeneca collaborated with the NHS clinics in July 2024 to add neurocosmetics to custom weight management and wellness programs. The strategy focused on emotional skin care, multi-morbidity prevention and preemptive wellness, raising awareness and continuing practice in patients with metabolic issues.</li> </ul> <ul> <li><strong>France: </strong>Roche introduced public health initiatives in February 2025, which provide neuro-active skincare items to individuals struggling with diabetes, obesity, and stress-related skin issues. In this method, awareness campaigns were used with clinical advice to help safeguard the proper use and maximize the benefits of the therapeutic.</li> </ul> <p><strong>Asia Pacific: </strong>The region is undergoing booming growth with the increasing obesity, diabetes and metabolic disease rates, increasing access to healthcare and the increasing population of urban areas.</p> <ul> <li><strong>China: </strong>Eli Lilly launched a digital adherence pilot program in March 2025 in hospitals to test neurocosmetic application programs based on the potential to enhance patient compliance and therapy results with the use of mobile health apps. The efforts made on emotional and cognitive skin advantages, which make neurocosmetics one of the aspects of holistic wellness.</li> </ul> <ul> <li><strong>India: </strong>Novo Nordisk introduced educationally supported subsidized neurocosmetic products in urban and rural hospitals in April 2025. This program would enhance the level of accessibility and affordability and raise awareness on functional skincare as it relates to stress, aging, and metabolic wellness.</li> </ul> <ul> <li><strong>Japan: </strong>In January 2025, Takeda collaborated with the local clinics in providing organized neurocosmetic therapy to elderly patients. The programs dealt with the management of type 2 diabetes and aging-related cognitive and emotional skin issues, which is characteristic of Japan, which is concerned with the care of the elderly and preventive healthcare.</li> </ul> <p><strong>LAMEA (Latin America, Middle East, Africa): </strong>LAMEA growth is being fueled by the rising levels of chronic disease awareness, the development of better healthcare systems, and efforts to offer cheap and affordable treatments.</p> <ul> <li><strong>Brazil: </strong>Novo Nordisk introduced clinics to train on safe effective use of neurocosmetic therapy for diabetes and obesity in June 2024. The programs increased the professional support of health care and patient trust in adopting therapy.</li> </ul> <ul> <li><strong>Saudi Arabia: </strong>In March 2025, Eli Lilly will roll out systematic awareness campaigns and programs in key hospitals to market the neurocosmetic treatments so that they can achieve emotional wellness and weight control. Through these programs, urban populations were supported and access and patient knowledge were enhanced.</li> </ul> <ul> <li><strong>South Africa: </strong>May 2024, Sanofi collaborated with local clinics to increase the availability of neurocosmetic treatments, specifically in urban areas experiencing an increase in the prevalence of chronic diseases. The activities were meant to inform patients, enhance compliance and enhance the market of neuro-active skincare.</li> </ul> <h3>Key Developments</h3> <ul> <li>In June 2025, <a href="https://www.loreal.com/en/">L'Oréal</a> has agreed to acquire a majority stake in the British skincare brand Medik8, valued at around 1 billion Euro, as part of its strategy to strengthen its presence in the luxury skincare market; the deal includes Inflexion retaining a minority share and L'Oréal securing an option for full ownership, with both companies expressing enthusiasm for future global growth and synergy, while Medik8’s science-driven, accessible products are viewed as a natural fit for L'Oréal’s luxe portfolio, pending regulatory approvals for finalization in the coming months.</li> </ul> <h3>Leading Players</h3> <p>The Neurocosmetics Market is highly competitive, with a large number of product providers globally. Some of the key players in the market include:</p> <ul> <li>LUKSO Neurocosmetics</li> <li>Justhuman / Swanrose Inc.</li> <li>GINGER & ME (INSKIN COSMEDICS)</li> <li>Algenist (The Algenist LLC)</li> <li>Arkana Cosmetics</li> <li>Sisley Cosmetics (Neuraé line)</li> <li>L’Oréal Group</li> <li>Estée Lauder Companies</li> <li>SkinSoul Cosmetics</li> <li>Amyris Inc.</li> <li>Others</li> </ul> <p>Personalized nutrition delivery software, functional wellness programs, and customized formulations propel the Global Neurocosmetics Market. Demand is seen in science-driven emotional skin care, anti-aging, and cognitive wellness. Key determinants include convenience, efficacy, digital interactivity, and homecare. Growth is evident in North America, Europe, Asia-Pacific, and LAMEA owing to patient education, regulatory matches, and sustainable production. Market accessibility, compliance, and digital efficiency are at the core of the value proposition.</p> <p>The <strong>Neurocosmetics Market</strong> is segmented as follows:</p> <p><strong>By Product Type</strong></p> <ul> <li>Body Care</li> <li>Face Care</li> <li>Hair Care</li> <li>Color Cosmetics</li> <li>Bath Products</li> <li>Other</li> </ul> <p><strong>By Consumer Group</strong></p> <ul> <li>Men</li> <li>Women</li> </ul> <p><strong>By Distribution Channel</strong></p> <ul> <li>Online</li> <li>Offline</li> </ul> <p><strong>Regional Coverage:</strong></p> <p><strong>North America</strong></p> <ul> <li>U.S.</li> <li>Canada</li> <li>Mexico</li> <li>Rest of North America</li> </ul> <p><strong>Europe</strong></p> <ul> <li>Germany</li> <li>France</li> <li>U.K.</li> <li>Russia</li> <li>Italy</li> <li>Spain</li> <li>Netherlands</li> <li>Rest of Europe</li> </ul> <p><strong>Asia Pacific</strong></p> <ul> <li>China</li> <li>Japan</li> <li>India</li> <li>New Zealand</li> <li>Australia</li> <li>South Korea</li> <li>Taiwan</li> <li>Rest of Asia Pacific</li> </ul> <p><strong>The Middle East & Africa </strong></p> <ul> <li>Saudi Arabia</li> <li>UAE</li> <li>Egypt</li> <li>Kuwait</li> <li>South Africa</li> <li>Rest of the Middle East & Africa</li> </ul> <p><strong>Latin America</strong></p> <ul> <li>Brazil</li> <li>Argentina</li> <li>Rest of Latin America</li> </ul>
Report Code
HF6761
Published
December 3, 2025
Pages
320+
Format
PDF, Excel
Revenue, 2024
—
Forecast, 2034
—
CAGR, 2025-2034
8.50%
Report Coverage
Global
Executive Summary
This report provides comprehensive analysis of the consumer goodssector in the healthcare industry. Our research covers market trends, key players, growth opportunities, and strategic recommendations.
Key Findings
- Market size and growth projections
- Competitive landscape analysis
- Regulatory environment overview
- Technology trends and innovations
Market Overview
The healthcare market continues to evolve with new technologies, changing regulations, and shifting patient demographics. This section provides detailed insights into current market conditions.
